Frailty and aging in cancer survivors
KK Ness, MD Wogksch - Translational Research, 2020 - Elsevier
There are over 15 million survivors of cancer in the United States whose rates of frailty, an
aging phenotype, range from just under 10% to over 80%. Frailty impacts not only disease …
aging phenotype, range from just under 10% to over 80%. Frailty impacts not only disease …
Frailty and aging in cancer survivors
KK Ness, MD Wogksch - Translational research: the …, 2020 - pubmed.ncbi.nlm.nih.gov
There are over 15 million survivors of cancer in the United States whose rates of frailty, an
aging phenotype, range from just under 10% to over 80%. Frailty impacts not only disease …
aging phenotype, range from just under 10% to over 80%. Frailty impacts not only disease …
[HTML][HTML] Frailty and aging in cancer survivors
KK Ness, MD Wogksch - … research: the journal of laboratory and …, 2020 - ncbi.nlm.nih.gov
There are over 15 million survivors of cancer in the United States whose rates of frailty, an
aging phenotype, range from just under ten to over eighty percent. Frailty impacts not only …
aging phenotype, range from just under ten to over eighty percent. Frailty impacts not only …
Frailty and aging in cancer survivors
KK Ness, MD Wogksch - Translational Research, 2020 - translationalres.com
There are over 15 million survivors of cancer in the United States whose rates of frailty, an
aging phenotype, range from just under 10% to over 80%. Frailty impacts not only disease …
aging phenotype, range from just under 10% to over 80%. Frailty impacts not only disease …
Frailty and aging in cancer survivors.
KK Ness, MD Wogksch - … Research: the Journal of Laboratory and …, 2020 - europepmc.org
There are over 15 million survivors of cancer in the United States whose rates of frailty, an
aging phenotype, range from just under ten to over eighty percent. Frailty impacts not only …
aging phenotype, range from just under ten to over eighty percent. Frailty impacts not only …